Totally (LON:TLY)‘s stock had its “buy” rating reiterated by equities researchers at Canaccord Genuity in a report issued on Monday, February 25th. They presently have a GBX 50 ($0.65) price objective on the health services provider’s stock. Canaccord Genuity’s price objective indicates a potential upside of 354.55% from the stock’s current price.
TLY stock traded down GBX 0.40 ($0.01) during midday trading on Monday, reaching GBX 11 ($0.14). The company had a trading volume of 281,503 shares, compared to its average volume of 19,696. The company has a debt-to-equity ratio of 0.03, a current ratio of 0.81 and a quick ratio of 0.81. Totally has a 1 year low of GBX 12 ($0.16) and a 1 year high of GBX 34.40 ($0.45). The stock has a market cap of $6.58 million and a PE ratio of 2.97.
Totally plc, through its subsidiaries, provides out-of-hospital healthcare services in the United Kingdom. The company offers a range of treatments and advice for musculoskeletal injuries and conditions, such as physiotherapy and podiatry to NHS patients; occupational health and ergonomic services to corporate clients, including display screen equipment assessments; post-injury returns to work suitability assessments; podiatry treatment; and sports massage services.
See Also: Why do companies engage in swaps?
Receive News & Ratings for Totally Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Totally and related companies with MarketBeat.com's FREE daily email newsletter.